Home > Back to Publisher > Report Information

Indian Generics, 2008-2012: The Growing Threat to Westernised Markets

Spectra Intelligence
January 1, 2008
138 Pages - SKU: SPIN1692980

Abstract Table of Contents Search inside this report Related Reports

Countries covered: India

Indian pharmaceutical companies are grabbing headlines on an almost daily basis and are increasingly carving out market shares for themselves in the US and many other markets around the world. Several leading Indian pharmaceutical companies have applied themselves to the challenge of entering Western markets with great success. These companies now present a very serious threat to the existing Western generic companies in their domestic markets as they take ever-larger market shares and increase the levels of competition.

The Challenge from Indian Generic Companies

Why has this challenge arisen - what advantages do Indian companies enjoy that enable them to compete so successfully with Western generic companies?

It is the purpose of this report to answer that question and to provide Western pharmaceutical companies and others that are interested by this phenomenon with some explanation of the background. It will also offer some guidance as to how companies might deal with what some see as a threat and others view as a welcome source of low-cost generics.

Executive Summary
1. INTRODUCTION TO THE INDIAN PHARMACEUTICAL INDUSTRY: 1.0 A Brief History; 1.1 The First Companies; 1.2 Government Measures to Encourage the Industry; 1.3 Leading Companies; 1.4 Changes in National Pharmaceutical Export-Import Ratios; 1.5 The Medium-to-Small Players; 1.6 Overseas Presence in the Indian Market
2. GROWTH OF THE INDIAN GENERICS INDUSTRY: 2.0 History of the Indian Generics Industry; 2.1 Origins - How did it all Start?; 2.2 Reverse Engineering; 2.3 Speed to Market; 2.4 Branded Generics - The Indian Way; 2.5 Growth Strategies and Drivers
3. INDIAN DRUG LEGISLATION: 3.0 Legislative Background; 3.1 The Drugs and Cosmetics Act, 1940; 3.2 Drug Policy of 1986; 3.3 Liberalisation Since 1991; 3.4 Pharmaceutical Registration; 3.5 Data Exclusivity; 3.6 Barriers to Foreign Ownership; 3.7 Price Controls; 3.8 Patents and Intellectual Property; 3.9 Export Incentives
4. THE INDIAN DRUG MARKET: 4.0 Domestic Market and Healthcare System; 4.1 Market Size and Drivers of Growth; 4.2 Leading Domestic Companies; 4.3 Leading Foreign Players; 4.4 The Indian Market in an International Context; 4.5 Market Growth - Past and Future; 4.6 The Healthcare System; 4.7 Traditional, Herbal and Ayurvedic Medicines; 4.8 Factors Influencing Pricing
5. COMPANY PROFILES: 5.1 [Company]; 5.2 [Company]; 5.3 [Company]; 5.4 [Company]; 5.5 [Company]; 5.6 [Company]; 5.7 [Company]; 5.8 [Company]; 5.9 [Company]; 5.10 [Company]
6. OUTLOOK FOR THE INDIAN GENERICS INDUSTRY: 6.1 Growth Opportunities and Possible Threats for Indian Companies; 6.2 Threats; 6.3 Research and Development
7. CONCLUSIONS AND INSIGHTS FOR THE INDIAN GENERICS MARKET: 7.1 Is India the Pharmaceutical Giant of the Future?; 7.2 Are Indian Companies Allies or Opponents?; 7.3 Who will be Tomorrow’s Generic Champions?
List of Tables: Table 1 Presence of Asian Pharmaceutical Companies at Annual Global Exhibitions, 1997-2005; Table 1.1 Pricing Differentials of Ciprofloxacin (10 × 500mg tablets) in 2006; Table 1.2 Price Comparisons of Doxycycline in Europe, the US, and India; Table 1.3 Top Ten Indian Pharmaceutical Companies by Turnover, 2005; Table 1.4 Annual Revenues of the Leading Indian Drug Manufacturers, 2006-2007; Table 1.5 Value Growth Trends of Drug Exports and Imports in India, 1999-2005 (Crore Rupees); Table 1.6 Domestic Sales of Medium-to-Small Sized Pharmaceutical Players (to March 2005); Table 1.7 Members of the Organisation of Pharmaceutical Producers of India; Table 2.1 List of Brand Names for Cephalexin, the Manufacturers and Price Comparisons; Table 2.2 Sales Distributions (%) of Selected Indian Drug Manufacturers by Region, 2006; Table 2.3 Ranbaxy Cases and Outcomes with Pfizer in Europe, 2005-2007; Table 2.4 Selected Indian Drug Company Acquisitions in North America; Table 2.5 Selected Indian Drug Company Acquisitions in Western Europe; Table 2.6 Selected Indian Drug Company Acquisitions in Eastern Europe; Table 3.1 Indian Trade Balance, 2000-2007 (US$m); Table 3.2 Comparison of Indian Data Exclusivity Proposals to Actual Practice in the West; Table 3.3 History of the Indian Patent System; Table 4.1 Analysis of Pharmaceutical Sales in India, Quarter ending March 2007; Table 4.2 Indices of Population and Economic Growth in India, 2004-2008; Table 4.3 Leading Indian Pharmaceutical Company Market Shares, 2004-2006; Table 4.4 Comparison of Indian Drug Sales by Value (US$m) with Key International Territories (2005-2006) and Population Statistics; Table 5.1 Annual Sales Figures (Rs and US$) for [Company], 2002-2007; Table 5.2 Annual Sales Figures (Rs and US$) for [Company], 2002-2007; Table 5.3 Annual Sales Figures (Rs and US$) for [Company], 2002-2007; Table 5.4 Annual Sales Figures (Rs and US$) for [Company], 2002-2007; Table 5.5 Major [Company] Brands and Sales (Rs and US$ million); Table 5.6 Annual Sales Figures (Rs and US$) for [Company], 2002-2007; Table 5.7 Annual Sales Figures (Rs and US$) for [Company], 2002-2007; Table 5.8 [Company] Major Domestic Brands and Sales (Rps million), 2006-2007; Table 5.9 Annual Sales Figures (Rs and US$) for [Company], 2002-2007; Table 5.10 Annual Sales Figures (Rs and US$) for [Company], 2002-2007; Table 5.11 Annual Sales Figures (Rs and US$) for [Company], 2002-2006; Table 5.12 Annual Sales Figures (Rs and US$) for [Company], 2002-2007

More India Manufacturing, Packaging & Detailing Reports

Oncology Pharmaceuticals Market in India 2012 by Netscribes (India) Pvt. Ltd.
Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in ...

Cardiovascular Pharmaceuticals Market in India 2012 by Netscribes (India) Pvt. Ltd.
Cardiovascular pharmaceuticals market in India is the second largest contributor to domestic pharmaceutical sales, contributing around 15.6%. Since India has a huge patient pool, the ...

Anti-Infective Pharmaceuticals Market in India 2012 by Netscribes (India) Pvt. Ltd.
Anti-infective pharmaceuticals market in India is the largest contributor to domestic pharmaceutical sales, contributing around 18%. Since India has a huge patient pool, the Indian ...

India Pharmaceutical Industry Research and Forecast to 2016 by AM Mindpower Solutions
EXECUTIVE SUMMARY The report titled “India Pharmaceutical Industry Research and Forecast to 2016” offer detailed analysis on the country’s bulk and formulations market which is sub-segmented ...

Anti-Diabetic Pharmaceuticals Market in India 2012 by Netscribes (India) Pvt. Ltd.
Anti-diabetic pharmaceuticals market in India is one of the most lucrative diabetes markets in the world. Since India is the second largest diabetic pool in ...

See all reports like this >>

More India Reports

D&B Country RiskLine Report: India by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: India by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report India January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Spirits - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Spirits - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...

Wine - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...

See all reports like this >>

Indian Generics, 2008-2012: The Growing Threat to Westernised Markets

Share this report

Other tasks

Research Assistance

Related Markets

Manufacturing, Packaging & Detailing Reports

Free Alert Me service